Current Report Filing (8-k)
February 24 2017 - 5:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report
(Date of earliest event reported): February 23, 2017
CV SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
|
000-54677
(Commission File Number)
|
80-0944970
(I.R.S. Employer Identification No.)
|
2688 South Rainbow Boulevard, Suite B
Las Vegas, Nevada 89146
(Address of
principal executive offices)
(866) 290-2157
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
|
☐
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d -2(b))
|
☐
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e -4(c))
|
Item 4.01 Changes
in Registrant’s Certifying Accountant.
On February
23, 2017, PKF, Certified Public Accountants, a professional corporation (“PKF”) resigned as the independent registered
public accounting firm of CV Sciences, Inc., a Delaware corporation (the “Company”).
The reports
of PKF regarding the Company’s financial statements for fiscal years ended December 31, 2014 and December 31, 2015 did not
contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting
principles. PKF did not report on the financial statements for the fiscal year ended December 31, 2016. During the fiscal years
ended December 31, 2014, December 31, 2015, and December 31, 2016 and during the period from December 31, 2016 through February
23, 2017, the date of resignation, there were no disagreements with PKF on any matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of PKF would have
caused it to make reference to such disagreement in its reports. No reportable events (as described in paragraph (a)(1)(v) of Item
304 of Regulation S-K) occurred during the fiscal years ended December 31, 2014, December 31, 2015 and/or December 31, 2016.
The Company
provided PKF with a copy of this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission and
requested that PKF furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether it agrees
with the above statements made by the Company in response to Item 304(a) of Regulation S-K and, if it does not agree, the respects
in which it does not agree. A copy of the letter, dated February 24, 2017, is filed as Exhibit 16.1 to this Current Report on Form
8-K and is incorporated by reference herein.
On February 23, 2017, the Company’s Board
of Directors approved the engagement of Tanner Co. (“Tanner Co.”), as its independent registered public accounting
firm. During the fiscal years ended December 31, 2015 and December 31, 2016 and the subsequent interim period through February
23, 2017, the date of engagement of Tanner Co., the Company did not consult with Tanner Co. regarding either (i) the application
of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered
on the Company’s financial statements, or (ii) any matter that was either the subject of a disagreement (as defined in paragraph
(a)(1)(iv) of Item 304 of Regulation S-K and the related instructions thereto) or a reportable event (as described in paragraph
(a)(1)(v) of Item 304 of Regulation S-K).
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits
16.1 Letter
from PKF to the Securities and Exchange Commission, dated February 24, 2017.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: February 24, 2017
|
CV SCIENCES, INC.
|
|
|
|
|
|
|
|
By:
/s/ Michael Mona, Jr.
|
|
Michael Mona, Jr.
|
|
President and Chief Executive Officer
|
CV Sciences (QB) (USOTC:CVSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
CV Sciences (QB) (USOTC:CVSI)
Historical Stock Chart
From Apr 2023 to Apr 2024